Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B-Bridge International is a private company founded in 2000 in Silicon Valley that supports Japanese and other companies entering and expanding in the U.S. market. Historically, the company has been involved in biotechnology reagent distribution and life science research tools, and third-party industry profiles still describe it as a supplier of reagents, tools, equipment, and contract services for researchers. Its current corporate website emphasizes broader incubation, human resource development, PR, and marketing services that connect Japan and the United States. The company appears to operate primarily as a cross-border business incubator and commercialization support firm rather than a drug developer. There is no clear evidence of a proprietary therapeutic pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on B-Bridge International.